Climb Bio, Inc. — Form D

Climb Bio, Inc. of WELLESLEY HILLS, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-04. The offering totals $110.1M, of which $110.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Susan AltschullerRelated PersonWellesley Hills, MA
Aoife BrennanRelated PersonWellesley Hills, MA
Alexander (Bo) ComboRelated PersonWellesley Hills, MA
Kimberlee DrapkinRelated PersonWellesley Hills, MA
Judith DunnRelated PersonWellesley Hills, MA
Andrew LevinRelated PersonBOSTON, MA
Stephen ThomasRelated PersonDallas, TX
Douglas WilliamsRelated PersonWellesley Hills, MA
Perrin WilsonRelated PersonWellesley Hills, MA
Andrew LevinDirectorBOSTON, MA
Andrew LevinExecutive OfficerBOSTON, MA
Stephen ThomasDirectorDallas, TX
Julio VegaExecutive OfficerCambridge, MA
Erin LavelleExecutive OfficerCharlottesville, VA
Liam RatcliffeDirectorNew York, NY
Adam RosenbergDirectorWilmington, DE
Simon TateDirectorWilmington, DE
Aoife BrennanDirectorWellesley Hills, MA
Aoife BrennanExecutive OfficerWellesley Hills, MA
Judith DunnDirectorWellesley Hills, MA
Valerie MorissetExecutive OfficerWilmington, DE
David-Alexandre GrosDirectorIrvine, CA
Robert AzelbyDirectorRedmond, WA
Robert AzelbyExecutive OfficerRedmond, WA
James BucherExecutive OfficerRedmond, WA

Other filings by this issuer (7)

FiledFormOfferingSold
2024-07-02D$120.0M$120.0M
2024-07-02D$41.9M$41.9M
2021-05-28D$60.0M$60.0M
2020-11-03D$50.0M$5.0M
2019-10-23D$10.0M$10.0M
2019-10-23D/A$16.3M$16.3M
2019-02-19D$12.2M$12.2M

More